You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
8 June 2026 - Hangzhou Sciwind Biosciences Co Ltd, a China-based, commercial-stage biopharmaceutical company focused on discovering and developing innovative therapies for metabolic diseases, announced on Sunday that key data from a head-to-head stud...
8 June 2026 - Commercial-stage biotech company Antengene Corporation Limited (SEHK:6996) announced on Sunday that it has presented the first preclinical data on ATG-207, alpha masked and TGF beta RIII-biased CD3-TGF-beta bifunctional fusion protein i...
8 June 2026 - Chinese biotechnology company OriCell Therapeutics Holdings Limited announced on Sunday that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China's National Medical Products Administra...
5 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) on Friday reported full results from the Phase III FIND-CKD trial evaluating Kerendia (finerenone) in adults with non-diabetic chronic kidney disease (nd-CK...
5 June 2026 - Insulin delivery and diabetes technology company Tandem Diabetes Care Inc (Nasdaq:TNDM) announced on Friday that it has received CE mark approval in Europe for expanded indications of its automated insulin delivery systems, enabling use...
5 June 2026 - Agentic AI company Owkin announced on Friday that it has entered into a multi-year collaboration with French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) to co-develop next-generation biopharma agents, supported by a...
5 June 2026 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq: GILD) and biotechnology company Lakefront Biotherapeutics NV (Euronext & Nasdaq: LKFT), formerly known as Galapagos, confirmed late Thursday the successful completion of the pre...